The linear mixed-effects analysis examined TNF-α levels over time (baseline, 3 months, 6 months) across the two cancer types (melanoma vs. NSCLC) and included random intercepts for each participant and accounted for autocorrelation with an AR (1) residual structure. This evidence concerns the gene TNF and non-small cell lung carcinoma.